251 related articles for article (PubMed ID: 10697516)
21. Influence of mistletoe lectins and cytokines induced by them on cell proliferation of human melanoma cells in vitro.
Thies A; Nugel D; Pfüller U; Moll I; Schumacher U
Toxicology; 2005 Feb; 207(1):105-16. PubMed ID: 15590126
[TBL] [Abstract][Full Text] [Related]
22. Mistletoe (viscum album) lectins as cytokine inducers and immunoadjuvant in tumor therapy. A review.
Bocci V
J Biol Regul Homeost Agents; 1993; 7(1):1-6. PubMed ID: 8346712
[TBL] [Abstract][Full Text] [Related]
23. AB-type lectin (toxin/agglutinin) from mistletoe: differences in affinity of the two galactoside-binding Trp/Tyr-sites and regulation of their functionality by monomer/dimer equilibrium.
Jiménez M; André S; Siebert HC; Gabius HJ; Solís D
Glycobiology; 2006 Oct; 16(10):926-37. PubMed ID: 16774910
[TBL] [Abstract][Full Text] [Related]
24. Complete amino acid sequence of the B chain of mistletoe lectin I.
Soler MH; Stoeva S; Voelter W
Biochem Biophys Res Commun; 1998 May; 246(3):596-601. PubMed ID: 9618256
[TBL] [Abstract][Full Text] [Related]
25. Paediatric medulloblastoma cells are susceptible to Viscum album (Mistletoe) preparations.
Zuzak TJ; Rist L; Eggenschwiler J; Grotzer MA; Viviani A
Anticancer Res; 2006; 26(5A):3485-92. PubMed ID: 17094471
[TBL] [Abstract][Full Text] [Related]
26. Isolation and partial characterization of a small chitin-binding lectin from mistletoe (Viscum album).
Peumans WJ; Verhaert P; Pfüller U; Van Damme EJ
FEBS Lett; 1996 Nov; 396(2-3):261-5. PubMed ID: 8914999
[TBL] [Abstract][Full Text] [Related]
27. Site-specific mutagenesis of mistletoe lectin: the role of RIP activity in apoptosis.
Langer M; Möckel B; Eck J; Zinke H; Lentzen H
Biochem Biophys Res Commun; 1999 Nov; 264(3):944-8. PubMed ID: 10544035
[TBL] [Abstract][Full Text] [Related]
28. Comparison of the effects of Viscum album lectin ML-1 and fresh plant extract (Isorel) on the cell growth in vitro and tumorigenicity of melanoma B16F10.
Zarković N; Kalisnik T; Loncarić I; Borović S; Mang S; Kissel D; Konitzer M; Jurin M; Grainza S
Cancer Biother Radiopharm; 1998 Apr; 13(2):121-31. PubMed ID: 10850348
[TBL] [Abstract][Full Text] [Related]
29. [Chimeric toxin of the A-subunit of viscumin and the B-subunit of ricin].
Tonevitskiĭ AG; Toptygin AIu; Agapov II; Shamshiev AT; Pfuller U; Ershova GV; Prokof'ev SA; Rakhmanova VA
Mol Biol (Mosk); 1994; 28(3):574-9. PubMed ID: 7519722
[TBL] [Abstract][Full Text] [Related]
30. [Analysis of major antigenic determinants in Mistletoe lectin I].
Maliuchenko NV; Moĭsenovich MM; Egorova SG; Gusarova VIu; Agapov II; Balashova TA; Tonevitskiĭ AG
Biofizika; 1999; 44(6):1017-21. PubMed ID: 10707276
[TBL] [Abstract][Full Text] [Related]
31. Effects of mistletoe lectin I on human blood cell lines and peripheral blood cells. Cytotoxicity, apoptosis and induction of cytokines.
Möckel B; Schwarz T; Zinke H; Eck J; Langer M; Lentzen H
Arzneimittelforschung; 1997 Oct; 47(10):1145-51. PubMed ID: 9368710
[TBL] [Abstract][Full Text] [Related]
32. Thionins from Viscum album L: influence of the viscotoxins on the activation of granulocytes.
Stein GM; Schaller G; Pfüller U; Schietzel M; Büssing A
Anticancer Res; 1999; 19(2A):1037-42. PubMed ID: 10368652
[TBL] [Abstract][Full Text] [Related]
33. Evaluating unconventional therapies.
Hajto T; Saller R
CMAJ; 1998 Oct; 159(7):759; author reply 759, 761. PubMed ID: 9805018
[No Abstract] [Full Text] [Related]
34. Is the binding of mistletoe lectins I and III a useful prognostic indicator in colorectal carcinoma?
Dixon A; Schumacher U; Pfüller U; Taylor I
Eur J Surg Oncol; 1994 Dec; 20(6):648-52. PubMed ID: 7995416
[TBL] [Abstract][Full Text] [Related]
35. Influence of carbohydrates on the cytotoxicity of an aqueous mistletoe drug and of purified mistletoe lectins tested on human T-leukemia cells.
Doser C; Doser M; Hülsen H; Mechelke F
Arzneimittelforschung; 1989 Jun; 39(6):647-51. PubMed ID: 2775329
[TBL] [Abstract][Full Text] [Related]
36. A new gene encoding the ribosome-inactivating protein from mistletoe extracts.
Tonevitsky AG; Agapov II; Pevzner IB; Maluchenko NV; Moisenovich MM; Palmer RA; Yurkova M; Pfüller K; Pfüller U
Arzneimittelforschung; 2004; 54(4):242-9. PubMed ID: 15146937
[TBL] [Abstract][Full Text] [Related]
37. Molecular characterization of the recombinant A-chain of a type II ribosome-inactivating protein (RIP) from Viscum album coloratum and structural basis on its ribosome-inactivating activity and the sugar-binding properties of the B-chain.
Ye W; Nanga RP; Kang CB; Song JH; Song SK; Yoon HS
J Biochem Mol Biol; 2006 Sep; 39(5):560-70. PubMed ID: 17002877
[TBL] [Abstract][Full Text] [Related]
38. [Histamine receptor-bearing lymphocytes. III. Suppression of immune reactions by killing of histamine receptor-bearing lymphocytes with a conjugate of histamine and the A chain of mistletoe lectin I].
Eckert R; Pfüller U; Kindt A; Reichelt E; Franz H
Biomed Biochim Acta; 1985; 44(7-8):1239-45. PubMed ID: 3878706
[TBL] [Abstract][Full Text] [Related]
39. Characterization of cytotoxic proteins from mistletoe (Viscum album L.).
Jung ML; Baudino S; Ribéreau-Gayon G; Beck JP
Cancer Lett; 1990 May; 51(2):103-8. PubMed ID: 2344587
[TBL] [Abstract][Full Text] [Related]
40. Internalization and action of an immunotoxin containing mistletoe lectin A-chain.
Wiedłocha A; Sandvig K; Walzel H; Radzikowsky C; Olsnes S
Cancer Res; 1991 Feb; 51(3):916-20. PubMed ID: 1988131
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
